Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

16.01.26 15:15 Uhr

Werte in diesem Artikel
Aktien

460,00 EUR -5,60 EUR -1,20%

Indizes

PKT PKT

25.529,3 PKT -17,8 PKT -0,07%

23.515,4 PKT -14,6 PKT -0,06%

6.940,0 PKT -4,5 PKT -0,06%

The upcoming report from Intuitive Surgical, Inc. (ISRG) is expected to reveal quarterly earnings of $2.25 per share, indicating an increase of 1.8% compared to the year-ago period. Analysts forecast revenues of $0 million, representing no change year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.With that in mind, let's delve into the average projections of some Intuitive Surgical metrics that are commonly tracked and projected by analysts on Wall Street.Analysts expect 'Revenue- Product (Instruments and accessories and Systems)' to come in at $2.31 billion. The estimate suggests a change of +11.7% year over year.Analysts predict that the 'Revenue- Services' will reach $403.40 million. The estimate suggests a change of +16.1% year over year.Analysts' assessment points toward 'Revenue- Systems' reaching $660.60 million. The estimate indicates a year-over-year change of +0.9%.The consensus estimate for 'Revenue- Instruments and accessories' stands at $1.65 billion. The estimate indicates a year-over-year change of +16.7%.The collective assessment of analysts points to an estimated 'Instruments and accessories Revenue- United States' of $1.15 billion. The estimate indicates a year-over-year change of +13.8%.The consensus among analysts is that 'Systems Revenue- United States' will reach $374.31 million. The estimate indicates a change of -11% from the prior-year quarter.Analysts forecast 'Instruments and accessories Revenue- Outside of the United States' to reach $480.60 million. The estimate indicates a change of +19.1% from the prior-year quarter.According to the collective judgment of analysts, 'Geographic Revenue- United States' should come in at $1.78 billion. The estimate suggests a change of +7.6% year over year.It is projected by analysts that the 'Total System Units Placed - Total Company' will reach 503 . Compared to the present estimate, the company reported 493 in the same quarter last year.The average prediction of analysts places 'Da Vinci Surgical System Installed Base' at 11,122 . Compared to the present estimate, the company reported 9,902 in the same quarter last year.Based on the collective assessment of analysts, 'Total System Units Placed - Outside of the United States' should arrive at 202 . Compared to the present estimate, the company reported 209 in the same quarter last year.The combined assessment of analysts suggests that 'Total System Units Placed - United States' will likely reach 305 . Compared to the current estimate, the company reported 284 in the same quarter of the previous year. View all Key Company Metrics for Intuitive Surgical here>>> Over the past month, shares of Intuitive Surgical have returned -3.7% versus the Zacks S&P 500 composite's +2% change. Currently, ISRG carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Intuitive Surgical und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Intuitive Surgical

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Intuitive Surgical Inc

Wer­bung

Analysen zu Intuitive Surgical Inc

DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
26.01.2018Intuitive Surgical HoldCanaccord Adams
18.07.2017Intuitive Surgical Sector PerformRBC Capital Markets
30.06.2017Intuitive Surgical NeutralCantor Fitzgerald
30.05.2017Intuitive Surgical HoldCanaccord Adams
17.04.2017Intuitive Surgical Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.01.2015Intuitive Surgical SellCRT Capital
22.10.2014Intuitive Surgical SellCRT Capital
09.01.2009Intuitive Surgical DowngradeBrean Murray, Carret & Co., LLC
26.08.2005Update Intuitive Surgical Inc. : UnderperformJefferies & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen